Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
ENESTfreedom is evaluating treatment-free remission (TFR) following frontline nilotinib in patients with chronic myeloid leukemia (CML) in chronic phase. Following our primary analysis at 48 weeks, we here provide an updated 96-week analysis.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 February 2018
|
| In: |
Journal of cancer research and clinical oncology
Year: 2018, Jahrgang: 144, Heft: 5, Pages: 945-954 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-018-2604-x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00432-018-2604-x
|
| Verfasserangaben: | David M. Ross, Tamas Masszi, María Teresa Gómez Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentin Garcia-Gutierrez, Norbert Gattermann, Philipp D. le Coutre, Bruno Martino, Susanne Saussele, Francis J. Giles, Jerald P. Radich, Giuseppe Saglio, Weiping Deng, Nancy Krunic, Véronique Bédoucha, Prashanth Gopalakrishna, Andreas Hochhaus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1733931198 | ||
| 003 | DE-627 | ||
| 005 | 20220818212015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200929s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00432-018-2604-x |2 doi | |
| 035 | |a (DE-627)1733931198 | ||
| 035 | |a (DE-599)KXP1733931198 | ||
| 035 | |a (OCoLC)1341367919 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ross, David M. |e VerfasserIn |0 (DE-588)1076984541 |0 (DE-627)835493423 |0 (DE-576)445815388 |4 aut | |
| 245 | 1 | 0 | |a Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib |b 96-week update of the ENESTfreedom study |c David M. Ross, Tamas Masszi, María Teresa Gómez Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentin Garcia-Gutierrez, Norbert Gattermann, Philipp D. le Coutre, Bruno Martino, Susanne Saussele, Francis J. Giles, Jerald P. Radich, Giuseppe Saglio, Weiping Deng, Nancy Krunic, Véronique Bédoucha, Prashanth Gopalakrishna, Andreas Hochhaus |
| 264 | 1 | |c 22 February 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.09.2020 | ||
| 520 | |a ENESTfreedom is evaluating treatment-free remission (TFR) following frontline nilotinib in patients with chronic myeloid leukemia (CML) in chronic phase. Following our primary analysis at 48 weeks, we here provide an updated 96-week analysis. | ||
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cancer research and clinical oncology |d Berlin : Springer, 1979 |g 144(2018), 5, Seite 945-954 |h Online-Ressource |w (DE-627)253769515 |w (DE-600)1459285-X |w (DE-576)072578319 |x 1432-1335 |7 nnas |a Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib 96-week update of the ENESTfreedom study |
| 773 | 1 | 8 | |g volume:144 |g year:2018 |g number:5 |g pages:945-954 |g extent:10 |a Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib 96-week update of the ENESTfreedom study |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00432-018-2604-x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200929 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 11 | ||
| 999 | |a KXP-PPN1733931198 |e 3763851631 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.1007/s00432-018-2604-x"],"eki":["1733931198"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 29.09.2020"],"relHost":[{"origin":[{"dateIssuedKey":"1979","publisherPlace":"Berlin ; Heidelberg","publisher":"Springer","dateIssuedDisp":"1979-"}],"title":[{"title":"Journal of cancer research and clinical oncology","subtitle":"official organ of the Deutsche Krebsgesellschaft","title_sort":"Journal of cancer research and clinical oncology"}],"id":{"issn":["1432-1335"],"zdb":["1459285-X"],"eki":["253769515"]},"part":{"text":"144(2018), 5, Seite 945-954","volume":"144","year":"2018","pages":"945-954","extent":"10","issue":"5"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"recId":"253769515","disp":"Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib 96-week update of the ENESTfreedom studyJournal of cancer research and clinical oncology","titleAlt":[{"title":"Cancer research and clinical oncology"}],"language":["eng","ger"],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"family":"Ross","display":"Ross, David M.","given":"David M.","role":"aut"},{"role":"aut","family":"Saußele","given":"Susanne","display":"Saußele, Susanne"}],"origin":[{"dateIssuedDisp":"22 February 2018","dateIssuedKey":"2018"}],"name":{"displayForm":["David M. Ross, Tamas Masszi, María Teresa Gómez Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentin Garcia-Gutierrez, Norbert Gattermann, Philipp D. le Coutre, Bruno Martino, Susanne Saussele, Francis J. Giles, Jerald P. Radich, Giuseppe Saglio, Weiping Deng, Nancy Krunic, Véronique Bédoucha, Prashanth Gopalakrishna, Andreas Hochhaus"]},"recId":"1733931198","title":[{"title_sort":"Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib","subtitle":"96-week update of the ENESTfreedom study","title":"Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib"}],"language":["eng"]} | ||
| SRT | |a ROSSDAVIDMDURABLETRE2220 | ||